Clinical trial
Trachoma Amelioration in Northern Amhara (TANA)
NCT00322972 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00322972 |
|---|---|
| Title | Trachoma Amelioration in Northern Amhara (TANA) |
| Official title | Eliminating Trachoma With Repeat Mass Drug Treatment |
| Acronym | TANA |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Trachoma, Chlamydia |
| Intervention type | Drug |
| Interventions | Mass treatment with oral azithromycin to an entire community |
| Enrollment | 33,000 |
| Start date | Jun 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | May 1, 2014 |
| First posted | May 9, 2006 |
| Last update posted | Sep 9, 2015 |
| Countries | Ethiopia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: